Clinical-stage biopharmaceutical company Tonix Pharmaceuticals Holding Corp. is dedicated to developing cutting-edge therapeutics and vaccines that can treat and prevent a wide range of human diseases and alleviate suffering. With a robust pipeline of product candidates focused on immunology, rare disease, infectious disease, and central nervous system (CNS) conditions, Tonix is poised to play a major role in shaping the future of the biopharmaceutical industry. Tonix's immunology portfolio includes an array of biologics designed to address organ transplant rejection, autoimmunity, and cancer. One standout product, TNX-1500, is an innovative humanized monoclonal antibody that targets CD40-ligand and is being developed to treat autoimmune conditions. Tonix's rare disease portfolio, meanwhile, includes TNX-2900, a promising therapy for the treatment of Prader-Willi syndrome. The company's infectious disease pipeline is also full of promise, with standout products such as TNX-801, a groundbreaking vaccine that could prevent both smallpox and monkeypox, and TNX-1840 and TNX-1850, live virus vaccines based on Tonix's recombinant pox vaccine (RPV) platform that could be crucial in the fight against COVID-19. In addition, Tonix's CNS portfolio is comprised of both small molecules and biologics that can treat pain, neurologic, psychiatric, and addiction conditions. TNX-102 SL, for example, is currently in mid-Phase 3 development and shows great promise as a treatment for fibromyalgia, while TNX-1900 could revolutionize the prevention of migraine headaches. Founded in 2007 and headquartered in Chatham, New Jersey, Tonix Pharmaceuticals Holding Corp. is poised to make a major impact on the biopharmaceutical industry, offering cutting-edge therapies that have the power to revolutionize the way we treat a wide range of human conditions.
Tonix Pharmaceuticals Holding Corp.'s ticker is TNXP
The company's shares trade on the NASDAQ stock exchange
They are based in New York City, New York
There are 11-50 employees working at Tonix Pharmaceuticals Holding Corp.
It is https://www.tonixpharma.com/
Tonix Pharmaceuticals Holding Corp. is in the Healthcare sector
Tonix Pharmaceuticals Holding Corp. is in the Biotechnology industry
The following five companies are Tonix Pharmaceuticals Holding Corp.'s industry peers: